Patients who have flu-like symptoms and are having trouble breathing should get quick treatment with the antiviral drugs Tamiflu or Relenza, even before getting a flu test, U.S. officials said on Tuesday.
A virus known to cause leukemia and tumors in animals can be found in some prostate tumors and might be one cause of prostate cancer, U.S. researchers reported on Monday.
Adverse events like fainting or nausea remain rare among young women and girls given Merck and Co's Gardasil vaccine against cervical cancer, U.S. researchers reported on Tuesday.
An experimental drug developed by scientists in China appears to be effective in killing roundworms, a parasite that lurks in the intestines and which affects nearly two billion people in tropical countries.
Mylan (MYL) has been approved to make a generic version of migraine headache medicine Imitrex from GlaxoSmithkline and is set to ship the drug immediately.
Children should not routinely be given flu drugs like Tamiflu since there is no clear evidence they prevent complications and potentially harmful side effects may outweigh any benefits, British researchers said on Monday.
Use of antidepressant drugs in the United States doubled between 1996 and 2005, probably because of a mix of factors, researchers reported on Monday.
Use of antidepressant drugs in the United States doubled between 1996 and 2005, probably because of a mix of factors, researchers reported on Monday.
Health officials trying to make best use of antiviral drugs to fight the new H1N1 flu need to do a better job of tracking and treating cases quickly, Italian researchers said on Monday.
One month on from a cancer scare that investors feared might sink sales of Sanofi-Aventis's diabetes treatment Lantus, the French drugmaker appears to have escaped the worst.
Global health officials stepped up efforts to prepare for quick vaccination against the H1N1 pandemic virus, saying on Friday it appeared now to be affecting older age groups spared earlier in the pandemic.
Vaccines should be ready within months for H1N1 flu, which could mutate and become more severe in winter, the World Health Organization said on Friday.
Vaccines should be ready within months for H1N1 flu, which could mutate and become more severe in winter, the World Health Organization said on Friday.
The new pandemic H1N1 is causing a brisk flu season in the Southern Hemisphere and U.S. health officials said on Thursday they want to move swiftly to approve a vaccine to battle it.
Sanofi-Aventis said on Wednesday a group of independent experts had concluded that studies highlighting a possible link between its Lantus diabetes drug and an increased risk of cancer were flawed.
The United States will spend another $1 billion on ingredients for an H1N1 vaccine, U.S. Health and Human Services Secretary Kathleen Sebelius said on Sunday.
